Malignant News and Research

RSS

Benefits of new health insurance reform law for Medicare recipients discussed in news conference

Speaker Nancy Pelosi, Health and Human Services Secretary Kathleen Sebelius, House Majority Leader Steny Hoyer, Barbara Kennelly of the National Committee to Preserve Social Security and Medicare, and Dr. Ben Williamowsky of Silver Spring, Md., a Medicare recipient, held a news conference today to discuss benefits of and misconceptions about the Affordable Care Act and Medicare.

27 May 2010

Modified measles virus may hold potential for treatment of medulloblastoma

The use of modified measles virus may represent a new treatment for a childhood brain tumor known as medulloblastoma, according to a new study appearing in Neuro-Oncology.

27 May 2010

Nottingham scientists given green light to test new vaccine for malignant melanoma

Nottingham scientists have been given the green light to test a vaccine which they hope could reverse, and even cure malignant melanoma, the most deadly type of skin cancer.

27 May 2010

Researchers report key cellular pathway in deadly brain cancer malignant glioma

Researchers at the University of Massachusetts Medical School report in the journal Nature Medicine on a cellular pathway in the deadly brain cancer malignant glioma, a pathway essential to the cancer's ability to grow - and a potential target for therapy that would stop the cancer's ability to thrive.

26 May 2010

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.

25 May 2010

Positive results from Phase 2 clinical trial for STA-9090 in Stage IIIB and Stage IV patients with NSCLC

Synta Pharmaceuticals Corp. today announced that clinical activity seen in the first stage of its trial for STA-9090 in Stage IIIB and Stage IV patients with non-small cell lung cancer, support advancing to the second stage of the trial. This result was achieved in the first pre-defined patient cohort to complete enrollment.

25 May 2010

Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVue system

The Barbara Ann Karmanos Cancer Institute announced today that its spin-off company Delphinus Medical Technologies, LLC, has secured $8 million in venture capital to start the commercialization process of SoftVue, an alternative to mammography.

25 May 2010

2010 ASCO Annual Meeting highlights new research findings on cancer

Experts from The Cancer Institute at NYU Langone Medical Center will present new research findings at the 46th Annual Meeting of The American Society of Clinical Oncology (ASCO) in Chicago, Illinois.

24 May 2010

Poor survival rates in non-Hodgkin's lymphoma patients attributed to lifestyle factors

A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.

24 May 2010

Caregivers can give complete clinical picture of brain cancer patients' condition

Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas -- primary brain tumors -- often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.

21 May 2010

Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the online-first publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

20 May 2010

MHAUS to discuss how medical facilities can best prepare for MH emergency

Preparation is the best plan for Malignant Hyperthermia emergencies, and The Malignant Hyperthermia Association of the United States will be at the Ambulatory Surgery Center Annual Meeting, May 19-22, to answer questions about how medical facilities can best prepare for an MH emergency.

20 May 2010

AACE, AME and ETA jointly publish guidelines for diagnosis and management of thyroid nodules

Three of the world's most respected medical associations for the treatment of thyroid disease recently issued joint guidelines for the diagnosis and management of thyroid nodules. The American Association of Clinical Endocrinologists, the Associazione Medici Endocrinologi and European Thyroid Association jointly published the guidelines online this week, and the executive summary will be published in the next issue of their respective journals.

20 May 2010

Researchers identify cancer gene that could help fight paediatric glioma

Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.

19 May 2010

Oncolytics announces publication of Phase Ia/Ib U.K. clinical trial results of REOLYSIN for cancer

Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.

19 May 2010

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.

18 May 2010

Most recurrences of HCC occur early after initial diagnosis and treatment: Research article

Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.

17 May 2010

Canadian cancer patients cross the border for second opinion

Two years ago, Beverlee London of Toronto was diagnosed with Stage I lung cancer. London was given the news by her lung specialist in Toronto that she had a malignant tumor on her right lung. She also decided at the time to visit the Barbara Ann Karmanos Cancer Center in Detroit for a second opinion, since she had family living in the area.

15 May 2010

3D test for diagnosing malignant melanoma

UK scientists have developed a 3D test for malignant melanoma that can identify problems not easily spotted in a standard two-dimensional view of the pattern on the skin. The researchers describe the technique in detail in the latest issue of the International Journal of Modelling, Identification and Control.

14 May 2010

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

New data from a multi-centric international registry study show that cellular-level imaging with Mauna Kea Technologies' Cellvizio®, the world's smallest microscope, appears to significantly improve a physician's ability to diagnose or rule out early forms of bile duct cancer during a standard endoscopic diagnostic exam.

14 May 2010

Malignant News and Research

Benefits of new health insurance reform law for Medicare recipients discussed in news conference

Modified measles virus may hold potential for treatment of medulloblastoma

Nottingham scientists given green light to test new vaccine for malignant melanoma

Researchers report key cellular pathway in deadly brain cancer malignant glioma

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

Positive results from Phase 2 clinical trial for STA-9090 in Stage IIIB and Stage IV patients with NSCLC

Delphinus Medical Technologies secures $8M in venture capital to commercialize SoftVue system

2010 ASCO Annual Meeting highlights new research findings on cancer

Poor survival rates in non-Hodgkin's lymphoma patients attributed to lifestyle factors

Caregivers can give complete clinical picture of brain cancer patients' condition

Study demonstrates anti-prostate cancer properties of Modified Citrus Pectin

MHAUS to discuss how medical facilities can best prepare for MH emergency

AACE, AME and ETA jointly publish guidelines for diagnosis and management of thyroid nodules

Researchers identify cancer gene that could help fight paediatric glioma

Oncolytics announces publication of Phase Ia/Ib U.K. clinical trial results of REOLYSIN for cancer

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Most recurrences of HCC occur early after initial diagnosis and treatment: Research article

Canadian cancer patients cross the border for second opinion

3D test for diagnosing malignant melanoma

Mauna Kea Technologies' Cellvizio improves diagnosis of early forms of bile duct cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News